Trump-Pfizer Deal Softens Tariff Blow, Sets Precedent for Drugmakers
Trump-Pfizer Deal Softens Tariff Blow, Sets Precedent for Drugmakers President Donald Trump’s long-anticipated threat to impose pharmaceutical tariffs may be losing its bite following a landmark drug pricing agreement struck with Pfizer on September 30, 2025. The deal signals a potential shift in the administration’s strategy, offering a pathway for other major drugmakers to avoid impending levies. Under the Tuesday agreement, Pfizer committed to voluntarily lowering U.S. drug prices for Medicaid and pledged an additional $70 billion in domestic manufacturing…